Tag: Amgen
Why Diversity Matters
Diversity widens viewpoints and takes different ideas and perspectives into account. This can translate into creating richer solutions, obtaining better results and maximizing productivity, innovation...
STEM Pathways to Biotech Careers
You’ve likely heard the term STEM, but what does it stand for? STEM is an acronym for science, technology, engineering, and math. These four...
The War for Life Sciences Talent: Creating Offers Beyond the...
In the ongoing “war for talent,” employers are having to come up with different strategies to find and keep top talent. In particular, the...
Women in Science: Cracking the Code
To stay competitive globally, the nation needs the talent and creative ability of all of its people—both women and men. However, women make up...
Making Sustainability Work: The Road to Net Zero
Sustainability is often defined as conducting business in an ethical manner that yields long-term, sustainable benefits, meeting the needs of the present without compromising...
Team approach allows Amgen to complete new biomanufacturing plant in 2020
PBN Manufacturing Awards 2021
Overall Excellence at an Enterprise Manufacturer: Amgen Rhode Island
Amgen Inc. develops medications for oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and...
Raimondo announces $45M in workforce development for the unemployed
PROVIDENCE – In an effort to break down traditional barriers to hiring, Gov. Gina M. Raimondo announced on Tuesday an investment of $45 million...
Amgen pulls high-price version of Repatha in bid to raise sales
NEW YORK – Amgen Inc. will pull its higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of...
Five Questions With: Carol Malysz
In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and...
Amgen will buy Celgene drug in $13.4B antitrust sale
BOSTON – Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to...